Next-Generation CRISPR Screening Platforms for Insights Into Human Disease Biology
The advent of programmable and sequence-specific technologies with the capacity to correct, replace and delete specific DNA sequences in cells has transformed modern biology and provides a highly efficient means for implementing therapeutic gene correction.
In this webinar, our expert speaker Dr. Laralynne Przybyla from the University of California San Francisco will focus on her current work at the Laboratory for Genomics Research on bringing together advances in iPSC differentiation, genetic engineering, CRISPR techniques and automation to improve the scale, robustness, cost and quality of functional genomics screens.
Attend this webinar to:
- Learn about current iPSC-derived models and limitations of current cell-based systems
- Explore the challenges around scalability of disease-relevant models and readouts as well as ongoing improvement strategies
- Discover new applications of CRISPRi and CRISPRa tools for functional genomics in human disease biology
- Engage in an informative live Q&A session with Dr. Przybyla